Brown, Lisle/Cummings, Inc. Gsk PLC Transaction History

Brown, Lisle/Cummings, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Jun 28, 2024	SELL	$16.13 - $44.61 $162,719 - $450,025	-10,088 Closed	0 $0
Q2 2022 Jun 28, 2024	BUY	$42.05 - $47.77 $756 - $859	18 Added 0.18%	10,088 $439 Million
Q1 2022 Jun 28, 2024	BUY	$40.23 - $47.74 $13,758 - $16,327	342 Added 3.52%	10,070 $439 Million
Q4 2021 Jun 28, 2024	BUY	$38.88 - $45.31 $378,224 - $440,775	9,728 New	9,728 $429 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $68.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Brown, Lisle/Cummings, Inc., based on Form 13F filings with the SEC.

Stay updated on Brown, Lisle/Cummings, Inc. with notifications on news.